Our study will provide new molecular mechanisms for the NEAT1-mediated cisplatin resistance of MB, contributing to the development of the lncRNA-based therapeutic approaches against chemoresistant medulloblastoma. The gene discussed is NEAT1; the disease is medulloblastoma.